ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Dabigatran etexilate
C34H41N7O5
627.7 g/mol
APIWarning

Prazaxa

CAS211915-06-9
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material

Prazaxa is a chemical compound used as an active pharmaceutical ingredient in pharmaceutical manufacturing. It is a highly flexible molecule with a complex structure containing multiple aromatic rings and functional groups, reflecting its role as a specialized pharmaceutical intermediate.

pharmaceutical manufacturing intermediate

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 211915-06-9

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongSame Parent

Pradaxa

CAS593282-20-3

pharmaceutical raw material

StrongSame Parent

Dabigatran etexilate mesylate

CAS872728-81-9

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.79

Ethyl 3-((2-((4-(N-hexoxycarbonylcarbamimidoyl)-N-nitrosoanilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoate

CAS2892260-29-4

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.79

Dabigatran impurity P

CAS1408238-37-8

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.76

N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride

CAS211914-50-0

pharmaceutical raw material

ReferenceSame Category

Asciminib hydrochloride

CAS2119669-71-3

pharmaceutical raw material

ReferenceSame Category

Calcitonin human

CAS21215-62-3

pharmaceutical raw material

ReferenceSame Category

(3ss)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4;

CAS2122245-62-7

pharmaceutical raw material

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name

ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate

InChIKey

KSGXQBZTULBEEQ-UHFFFAOYSA-N

SMILES

CCCCCCOC(=O)NC(=N)C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4

Synonyms (30)
  • Dabigatran etexilate (USAN/INN)
  • Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate (INN)
  • BIBR 1048 BS RS1
  • DABIGATRAN ETEXILATE [MART.]
  • Dabigatran Etexilate
  • Dabigatran hydrochloride
  • Dabigatran impurity 92
  • Etexilate, Dabigatran
  • Pradax
  • Prazaxa